Mary Jenkins | Manager-Investor Relations |
Doug Ingram | President and Chief Executive Officer |
Bo Cumbo | Executive Vice President and Chief Commercial Officer |
Ian Estepan | Senior Vice President, Chief of Staff and Corporate Affairs |
Gilmore O’Neill | Executive Vice President-R&D and Chief Medical Officer |
Louise Rodino-Klapac | Senior Vice President-Gene Therapy |
Tazeen Ahmad | Bank of America |
Salveen Richter | Goldman Sachs |
Anupam Rama | JPMorgan |
Max Skor | Morgan Stanley |
Mark Connolly | Credit Suisse |
Alethia Young | Cantor Fitzgerald |
Tyler Van Buren | Piper Sandler |
Brian Abrahams | RBC Capital Markets |
Gena Wang | Barclays |
Shawn Egan | Citi |
Vincent Chen | Bernstein |
Joseph Schwartz | SVB Leerink |
Difei Yang | Mizuho Securities |
Good day, ladies and gentlemen, and welcome to the Sarepta Therapeutics Second Quarter 2020 Earnings Call. [Operator Instructions] As a reminder, today’s program is being recorded. At this time, I’ll turn the call over to Mary Jenkins, Manager, Investor Relations. Please go ahead.
Thank you, operator and thank you all for joining today’s call.